Hyperinflammatory environment drives dysfunctional myeloid cell effector response to bacterial challenge in COVID-19 S Mairpady Shambat, A Gomez-Mejia, TA Schweizer, M Huemer, ... PLoS pathogens 18 (1), e1010176, 2022 | 30 | 2022 |
Blunted sFasL signalling exacerbates TNF‐driven neutrophil necroptosis in critically ill COVID‐19 patients TA Schweizer, S Mairpady Shambat, C Vulin, S Hoeller, C Acevedo, ... Clinical & translational immunology 10 (12), e1357, 2021 | 24 | 2021 |
Lactobacillus rhamnosus JB3 inhibits Helicobacter pylori infection through multiple molecular actions AD Do, CC Chang, CH Su, YM Hsu Helicobacter 26 (3), e12806, 2021 | 21 | 2021 |
Serine-threonine phosphoregulation by PknB and Stp contributes to quiescence and antibiotic tolerance in Staphylococcus aureus M Huemer, S Mairpady Shambat, S Hertegonne, J Bergada-Pijuan, ... Science Signaling 16 (766), eabj8194, 2023 | 8 | 2023 |
Novel virulence role of pneumococcal NanA in host inflammation and cell death through the activation of inflammasome and the caspase pathway YW Tseng, CC Chang, YC Chang Frontiers in Cellular and Infection Microbiology 11, 613195, 2021 | 7 | 2021 |
Neutrophil and monocyte dysfunctional effector response towards bacterial challenge in critically-ill COVID-19 patients SM Shambat, A Gómez-Mejia, TA Schweizer, M Huemer, CC Chang, ... bioRxiv, 2020.12. 01.406306, 2020 | 7 | 2020 |
Ser/Thr phospho-regulation by PknB and Stp mediates bacterial quiescence and antibiotic persistence in Staphylococcus aureus M Huemer, SM Shambat, S Pereira, L Van Gestel, J Bergada-Pijuan, ... BioRxiv, 2021.05. 06.442895, 2021 | 5 | 2021 |
Antiphospholipid antibodies are enriched post-acute COVID-19 but do not modulate the thrombotic risk M Emmenegger, V Emmenegger, SM Shambat, TC Scheier, ... Clinical Immunology 257, 109845, 2023 | 4 | 2023 |
Blunted Fas signaling favors RIPK1-driven neutrophil necroptosis in critically ill COVID-19 patients TA Schweizer, SM Shambat, C Vulin, S Hoeller, C Acevedo, M Huemer, ... bioRxiv, 2021.03. 19.436166, 2021 | 2 | 2021 |
MEndoB, a chimeric lysin featuring a novel domain architecture and superior activity for the treatment of staphylococcal infections C Roehrig, M Huemer, D Lorgé, F Arn, N Heinrich, L Selvakumar, ... Mbio 15 (2), e02540-23, 2024 | 1 | 2024 |
Systemic application of bone-targeting peptidoglycan hydrolases as a novel treatment approach for staphylococcal bone infection AP Keller, M Huemer, CC Chang, S Mairpady Shambat, C Bjurnemark, ... Mbio 14 (5), e01830-23, 2023 | 1 | 2023 |